Meridian Bioscience Inc (NASDAQ:VIVO)

Delayed Data
As of Nov 25
 +0.01 / +0.03%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Meridian Bioscience Inc have a median target of 62.00, with a high estimate of 62.00 and a low estimate of 62.00. The median estimate represents a +93.81% increase from the last price of 31.99.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Meridian Bioscience Inc. This rating has held steady since October, when it was upgraded from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Jan 26

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 25.00%
Growthannually -38.41%


Growthquarterly 19.68%
Growthannually -12.41%
Key to the earnings and sales forecast charts.